Sort
40,608 grants matching “prostate cancer”
Hexokinase 2 and cancer therapy
$574,013Nissim Hay · University Of Illinois At Chicago · R01 · FY2025 · CA
Case-Control Study of Pancreas Cancer Etiologic Factors
$574,007Harvey A Risch · Yale University · R01 · FY2008 · CA
Alpha-Particle Emitter Radiopharmaceutical Therapy for Liver Cancer
$574,001Jessie Nedrow · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer Progression
$573,873Kenneth J. Pienta · University Of Michigan At Ann Arbor · U01 · FY2010 · CA
Bionanotechnology approach for treatment of lung cancer
$573,870Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2022 · CA
High-Specificity Imaging Agents for Aggressive Prostate Cancer
$573,775Martin G Pomper · Johns Hopkins University · R01 · FY2015 · CA
OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER
$573,730University Of California Berkeley · R33 · FY2003 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$573,692James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Vaccine and radiation for the therapy of human cancers
$573,692James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
ITRACONAZOL, AN ANTIFUNGAL AND A HEDGEHOG PATHWAY INHIBITOR FOR TREATMENT OF PROSTATE CANCER
$573,674University Of Wisconsin System · · FY2015 · Department of Defense
San Juan Minority-Based Community Clinical Oncology Program
$573,647Luis Baez · Municipio De San Juan · U10 · FY2013 · CA
Whitlockite nanoparticle-based immunotherapy for bone metastasis
$573,510Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2019 · CA
Rad-pathomic deep learning models to assist radiologists in differentiating aggressive from indolent prostate cancer on MRI
$573,475Mirabela Rusu · Stanford University · R37 · FY2022 · CA
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)
$573,432Kerri M Winters-Stone · Oregon Health & Science University · R01 · FY2025 · CA
AUTOPHAGOSOMAL SEQUESTRATION OF MITOCHONDRIA AS AN INDICATOR OF ANTIANDROGEN THERAPY RESISTANCE OF PROSTATE CANCER (PCA)
$573,326University Of Wisconsin System · · FY2015 · Department of Defense
Tumor-specific autoantibodies for SCLC early detection
$573,272A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
NF-KAPPAB2/P52 ACTIVATION AND ANDROGEN RECEPTOR SIGNALING IN PROSTATE CANCER
$573,176University Of California, Davis · · FY2009 · Department of the Army
The Effect of Diet and Nutrients on the Progression and Treatment of Prostate Can
$573,098George Thomas · University Of Cincinnati · U01 · FY2013 · CA
"Statistical Methods for Genetic Epidemiology"
$573,074Alice S Whittemore · Stanford University · R01 · FY2009 · CA
Computer Support for the Colon Cancer Screening in PLCO Cancer Screening Trials
$573,034William Lake · Information Management Services, Inc. · N02 · FY2011 · CA
Discovery and qualification of transcriptomic biomarkers for the early detection of aggressive prostate cancer
$573,018Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U01 · FY2017 · CA
CANCER AND LEUKEMIA GROUP B
$572,909Brigham And Women'S Hospital · U10 · FY2000 · CA
MOLECULAR TARGETING OF PROSTATE CANCER DURING ANDROGEN ABLATION: INHIBITION OF CHES1/FOXN3
$572,887University Of California, Davis · · FY2009 · Department of Defense
THE POTENTIAL OF NONCODING RNAS IN SALIVA AND URINE AS BIOMARKERS OF PROSTATE CANCER
$572,878University Of Technology Sydney · · FY2011 · Department of Defense
Prostate Cancer Risk Enhancers
$572,877Gerhard A Coetzee · University Of Southern California · R01 · FY2015 · CA